Abstract
The integration between medicine and psychology is generally accepted, but in particular it is crucial to understand and treat cancer. Today it is known that, in addition to the genomic alterations that may undoubtedly be present, epigenetic alterations play a fundamental role.
The purpose of this article is to discuss recent evidence indicating that psychological distress resulting from a cancer diagnosis worsens prognosis if not adequately treated. Unfortunately, most of the people with cancer do not receive adequate and competent psychological help but, as frequently happens, just anxiolytics and antidepressants, whose effectiveness, in these cases, is questionable due to the risks of negative effects on the brain (cognitive deficits) and in the immune system.
Chronic stress and trauma imprint an epigenetic signature on the brain and immune system (IS) cells, which induce chronic neuroinflammation and immune dysregulation. Sustained stimulation of the stress system induces a "conserved transcriptional response to adversity (CTRA)" in peripheral immune cells. This is manifested by increased expression of pro-inflammatory genes (including IL-1β, IL-6 and TNF-α) and decreased expression of genes that modulate the synthesis of antibodies and antiviral molecules (type 1 immune circuit). Thus, the inactivation of the type 1 immune circuit exposes people to a greater risk of developing cancer and viral infections.
There is well-founded evidence of the relationship between stress and cancer from animal research. These results show the participation of the immune system in the control of initiation, growth and metastasis, disturbing the response of cytotoxic lymphocytes and NK cells, important members of the Type 1 circuit.
There is also growing evidence from human studies being the best established those coming from studies in the post-diagnosis phase. As it will be discussed, it has been shown that women with adequate social integration have better survival after colorectal cancer diagnosis. In addition several meta-analyses link depression, loneliness and social isolation with a reduced survival rate of cancer patients.
References
Abate, M., Citro, M., Caputo, M., Pisanti, S. y Martinelli, R. (2020). Psychological Stress and Cancer: New Evidence of An Increasingly Strong Link. Translational medicine @ UniSa, 23, 53–57. https://doi.org/10.37825/2239-9747.1010
Andersen, B. L., Yang, H. C., Farrar, W. B., Golden-Kreutz, D. M., Emery, C. F., Thornton, L. M., Young, D. C. y Carson, W. E., 3rd (2008). Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer, 113(12), 3450–3458. https://doi.org/10.1002/cncr.23969
Angell M. (1985). Disease as a reflection of the psyche. The New England journal of medicine, 312(24), 1570–1572. https://doi.org/10.1056/NEJM198506133122411
Bottaccioli F. y Bottaccioli A. G. (2017) Psiconeuroendocrinoimmunologia e scienza della cura integrata. Il Manuale, Edra, Milano.
Bottaccioli F. y Bottaccioli A. G. (2022) Fondamenti di Psiconeuroendocrinoimmunologia. III edizione, RED, Milano.
Bower, J. E., Kuhlman, K. R., Ganz, P. A., Irwin, M. R., Crespi, C. M. y Cole, S. W. (2020). Childhood maltreatment and monocyte gene expression among women with breast cancer. Brain, behavior, and immunity, 88, 396–402. https://doi.org/10.1016/j.bbi.2020.04.001
Bower, J. E., Shiao, S. L., Sullivan, P., Lamkin, D. M., Atienza, R., Mercado, F., Arevalo, J., Asher, A., Ganz, P. A. y Cole, S. W. (2018). Prometastatic Molecular Profiles in Breast Tumors From Socially Isolated Women. JNCI cancer spectrum, 2(3), pky029. https://doi.org/10.1093/jncics/pky029.
Brandt, J. y Leong, C. (2017). Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research. Drugs in R&D, 17(4), 493–507. https://doi.org/10.1007/s40268-017-0207-7.
Cassileth, B. R., Lusk, E. J., Miller, D. S., Brown, L. L. y Miller, C. (1985). Psychosocial correlates of survival in advanced malignant disease?. The New England journal of medicine, 312(24), 1551–1555. https://doi.org/10.1056/NEJM198506133122406.
Chida, Y., Hamer, M., Wardle, J. y Steptoe, A. (2008). Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nature clinical practice. Oncology, 5(8), 466–475. https://doi.org/10.1038/ncponc1134.
Eckerling, A., Ricon-Becker, I., Sorski, L., Sandbank, E. y Ben-Eliyahu, S. (2021). Stress and cancer: mechanisms, significance and future directions. Nature reviews. Cancer, 21(12), 767–785. https://doi.org/10.1038/s41568-021-00395-5.
Eng, J. W., Kokolus, K. M., Reed, C. B., Hylander, B. L., Ma, W. W. y Repasky, E. A. (2014). A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response. Cancer immunology, immunotherapy : CII, 63(11), 1115–1128. https://doi.org/10.1007/s00262-014-1617-9.
Feller, S., Teucher, B., Kaaks, R., Boeing, H. y Vigl, M. (2013). Life satisfaction and risk of chronic diseases in the European prospective investigation into cancer and nutrition (EPIC)-Germany study. PloS one, 8(8), e73462. https://doi.org/10.1371/journal.pone.0073462.
Giese-Davis, J., Collie, K., Rancourt, K. M., Neri, E., Kraemer, H. C. y Spiegel, D. (2011). Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 29(4), 413–420. https://doi.org/10.1200/JCO.2010.28.4455.
Karmakar, S. y Lal, G. (2021). Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics, 11(11), 5296–5312. https://doi.org/10.7150/thno.55986.
Kelly-Irving, M., Lepage, B., Dedieu, D., Lacey, R., Cable, N., Bartley, M., Blane, D., Grosclaude, P., Lang, T. y Delpierre, C. (2013). Childhood adversity as a risk for cancer: findings from the 1958 British birth cohort study. BMC public health, 13, 767. https://doi.org/10.1186/1471-2458-13-767.
Lutgendorf, S. K., Penedo, F., Goodheart, M. J., Dahmoush, L., Arevalo, J. M. G., Thaker, P. H., Slavich, G. M., Sood, A. K. y Cole, S. W. (2020). Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation. Cancer, 126(19), 4407–4413. https://doi.org/10.1002/cncr.33060.
Peng, T. R., Yang, L. J., Wu, T. W. y Chao, Y. C. (2020). Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies. Medicina (Kaunas, Lithuania), 56(10), 513. https://doi.org/10.3390/medicina56100513.
Ridout, K. K., Levandowski, M., Ridout, S. J., Gantz, L., Goonan, K., Palermo, D., Price, L. H. y Tyrka, A. R. (2018). Early life adversity and telomere length: a meta-analysis. Molecular psychiatry, 23(4), 858–871. https://doi.org/10.1038/mp.2017.26.
Satin, J. R., Linden, W. y Phillips, M. J. (2009). Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer, 115(22), 5349–5361. https://doi.org/10.1002/cncr.24561.
Spiegel D. (2002). Effects of psychotherapy on cancer survival. Nature reviews. Cancer, 2(5), 383–389. https://doi.org/10.1038/nrc800.
Stagl, J. M., Lechner, S. C., Carver, C. S., Bouchard, L. C., Gudenkauf, L. M., Jutagir, D. R., Diaz, A., Yu, Q., Blomberg, B. B., Ironson, G., Glück, S. y Antoni, M. H. (2015). A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up. Breast cancer research and treatment, 154(2), 319–328. https://doi.org/10.1007/s10549-015-3626-6.
Villalón L. F. J. (2023a). Mindfulness, compasión e Inter cuidado: el programa de Inter cuidado basado en atención Plena (IBAP). Pinelatinoamericana, 3(2), 103–114. Recuperado a partir de https://revistas.unc.edu.ar/index.php/pinelatam/article/view/41184
Villalón L. F. J. (2023b). Mindfulness, compasión e intercuidado: su marco conceptual. Pinelatinoamericana, 3(1), 42–53. Recuperado a partir de https://revistas.unc.edu.ar/index.php/pinelatam/article/view/40756.
Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y. y Wang, Z. (2020). Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Molecular psychiatry, 25(12), 3186–3197. https://doi.org/10.1038/s41380-020-00865-6.
Zhang, L., Pan, J., Chen, W., Jiang, J. y Huang, J. (2020). Chronic stress-induced immune dysregulation in cancer: implications for initiation, progression, metastasis, and treatment. American journal of cancer research, 10(5), 1294–1307.
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2024 Pinelatinoamericana